{
  "links": "https://www.ycombinator.com/companies/data-driven-bioscience",
  "name": "Data Driven Bioscience",
  "headline": "Cancer Diagnosis 10X faster, 10X cheaper",
  "batch": "S18",
  "description": null,
  "activity_status": "Active",
  "website": "http://datadrivenbioscience.com",
  "founded_date": 2018.0,
  "team_size": 10.0,
  "location": "Durham, NC",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:artificial-intelligence; industry:biotech; industry:healthcare",
  "founders": [],
  "status": true,
  "markdown": "raw_markdown='[![image43](http://img1.wsimg.com/isteam/ip/2265eb86-4f9e-4d91-b600-894aa4b4581b/Primary%20Vertical%20Full%20Color%20Light%20Theme.png/:/rs=h:148/ll)](http://datadrivenbioscience.com/</>)\\n[![image44](http://img1.wsimg.com/isteam/ip/2265eb86-4f9e-4d91-b600-894aa4b4581b/Primary%20Vertical%20Full%20Color%20Light%20Theme.png/:/rs=h:148/ll)](http://datadrivenbioscience.com/</>)\\n# Clinic Ready Genomics\\nClinic Ready GenomicsClinic Ready GenomicsClinic Ready Genomics\\n[Contact Us](http://datadrivenbioscience.com/</#fc8ca252-4c9e-480f-8fd5-9d3c2718d4e2>)\\n## What We Do\\nWe have created the tools for clinical labs to apply genomics for the diagnosis and treatment of\\ncancers.\\n![image45](http://img1.wsimg.com/isteam/ip/2265eb86-4f9e-4d91-b600-894aa4b4581b/molecular.png/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:600,h:300,cg:true/qt=q:1)\\n#### Molecularly defining responders in Clinical Trials\\nClinical trials in cancer patients are challenging. Failure rates are high. \\nSerious adverse events can occur frequently. However, even when a minority of patients respond to therapy, genomics could identify those patients for personalized therapy.\\nWe provide clinically translatable discovery genomics (DuoSeq), companion diagnostic development and FDA representation to enable the molecular definition of responders and patients at risk for significant adverse events.\\n![image46](http://img1.wsimg.com/isteam/ip/2265eb86-4f9e-4d91-b600-894aa4b4581b/duoseq.png/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:600,h:300,cg:true/qt=q:1)\\n#### DuoSeq: Clinical DNA and RNA sequencing\\nDuoSeq provides clinic-ready preparation of DNA and RNA sequencing libraries from a single specimen. Sequence whole exomes or selected gene panels (US FDA approval pending).\\nDuoSeq includes a complete solution for bioinformatics and variant annotation. This enables any lab with a sequencer to perform DNA and RNA sequencing without major investments in biocomputing infrastructure and personnel. \\n## Contact Us\\n#### Data Driven Bioscience\\n4711 Hope Valley Road, Durham, North Carolina 27707, United States\\n#### Hours\\nMonday - Friday: 8:00am - 6:00pm\\nSaturday - Sunday: Closed\\nCopyright © 2019 Data Driven Bioscience - All Rights Reserved.\\n' markdown_with_citations='![image43⟨1⟩](http://datadrivenbioscience.com/</>)\\n![image44⟨1⟩](http://datadrivenbioscience.com/</>)\\n# Clinic Ready Genomics\\nClinic Ready GenomicsClinic Ready GenomicsClinic Ready Genomics\\nContact Us⟨2⟩\\n## What We Do\\nWe have created the tools for clinical labs to apply genomics for the diagnosis and treatment of\\ncancers.\\n![image45⟨3⟩]\\n#### Molecularly defining responders in Clinical Trials\\nClinical trials in cancer patients are challenging. Failure rates are high. \\nSerious adverse events can occur frequently. However, even when a minority of patients respond to therapy, genomics could identify those patients for personalized therapy.\\nWe provide clinically translatable discovery genomics (DuoSeq), companion diagnostic development and FDA representation to enable the molecular definition of responders and patients at risk for significant adverse events.\\n![image46⟨4⟩]\\n#### DuoSeq: Clinical DNA and RNA sequencing\\nDuoSeq provides clinic-ready preparation of DNA and RNA sequencing libraries from a single specimen. Sequence whole exomes or selected gene panels (US FDA approval pending).\\nDuoSeq includes a complete solution for bioinformatics and variant annotation. This enables any lab with a sequencer to perform DNA and RNA sequencing without major investments in biocomputing infrastructure and personnel. \\n## Contact Us\\n#### Data Driven Bioscience\\n4711 Hope Valley Road, Durham, North Carolina 27707, United States\\n#### Hours\\nMonday - Friday: 8:00am - 6:00pm\\nSaturday - Sunday: Closed\\nCopyright © 2019 Data Driven Bioscience - All Rights Reserved.\\n' references_markdown='\\n\\n## References\\n\\n⟨1⟩ http://img1.wsimg.com/isteam/ip/2265eb86-4f9e-4d91-b600-894aa4b4581b/Primary%20Vertical%20Full%20Color%20Light%20Theme.png/:/rs=h:148/ll: ![image43\\n⟨2⟩ http://datadrivenbioscience.com/</#fc8ca252-4c9e-480f-8fd5-9d3c2718d4e2>: Contact Us\\n⟨3⟩ http://img1.wsimg.com/isteam/ip/2265eb86-4f9e-4d91-b600-894aa4b4581b/molecular.png/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:600,h:300,cg:true/qt=q:1: image45\\n⟨4⟩ http://img1.wsimg.com/isteam/ip/2265eb86-4f9e-4d91-b600-894aa4b4581b/duoseq.png/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:600,h:300,cg:true/qt=q:1: image46\\n' fit_markdown='' fit_html=''",
  "generated_description": "**Data Driven Bioscience: Revolutionizing Cancer Diagnosis**\n\nFounded in 2018 and hailing from the Y Combinator Batch S18, Data Driven Bioscience is on a mission to make cancer diagnosis 10 times faster and 10 times more affordable. The company is based in Durham, NC, and currently operates with a lean team of 10 employees. Their focus is clear: leveraging advanced genomics to enhance cancer treatment and diagnosis.\n\n**What Do They Do?**\n\nData Driven Bioscience has developed a suite of tools aimed at clinical labs that seek to apply genomics to cancer diagnosis and treatment. Their flagship product, **DuoSeq**, streamlines the process of preparing DNA and RNA sequencing libraries from a single specimen. This solution allows labs—without the need for extensive biocomputing investments—to perform comprehensive genomic sequencing quickly and efficiently. What's more, they’re in the process of securing FDA approval, which indicates a commitment to meeting rigorous industry standards.\n\n**Personalized Therapy and Clinical Trials**\n\nNavigating clinical trials can be a daunting task due to high failure rates and potential adverse events. Data Driven Bioscience helps define molecular responders to therapies, allowing for a personalized approach to treatment. Their companion diagnostic development and robust FDA representation bolster this capability—ensuring that the right patients receive the right therapies.\n\n**A Closer Look at DuoSeq**\n\n- **Ease of Use**: DuoSeq simplifies DNA and RNA sequencing library preparation, ensuring that labs can conduct tests without needing extensive technical resources.\n- **Comprehensive Bioinformatics**: The platform focuses on providing a complete bioinformatics solution for variant annotation, so labs can quickly interpret results.\n\n**The Bigger Picture**\n\nWith tags like 'artificial-intelligence', 'biotech', and 'healthcare', it's clear that Data Driven Bioscience is not just a player in the healthcare space but aims to redefine it. Their innovative approach could be game-changing, making personalized cancer treatment more accessible and efficient.\n\nFor anyone interested in the nuances of genomic diagnostics and cancer treatment, Data Driven Bioscience stands as a beacon of innovation. You can learn more about their pioneering work by visiting [their website](http://datadrivenbioscience.com)."
}